Stability of linezolid activity in an era of mobile oxazolidinone resistance determinants: results from the 2009 Zyvox® Annual Appraisal of Potency and Spectrum program (Q42795664)

From Wikidata

Jump to navigation Jump to search

scientific article published on December 1, 2010

Language	Label	Description	Also known as
English	Stability of linezolid activity in an era of mobile oxazolidinone resistance determinants: results from the 2009 Zyvox® Annual Appraisal of Potency and Spectrum program	scientific article published on December 1, 2010

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

7 November 2017

Stability of linezolid activity in an era of mobile oxazolidinone resistance determinants: results from the 2009 Zyvox® Annual Appraisal of Potency and Spectrum program (English)

1 reference

Europe PubMed Central

PubMed publication ID

7 November 2017

1 reference

based on heuristic

inferred from title

5

object named as

Ronald N Jones

1 reference

Europe PubMed Central

PubMed publication ID

7 November 2017

Rodrigo E. Mendes

3

object named as

Rodrigo E Mendes

1 reference

Europe PubMed Central

PubMed publication ID

7 November 2017

author name string

Douglas J. Biedenbach

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:21094428

31 August 2024

David J. Farrell

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:21094428

31 August 2024

James E. Ross

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:21094428

31 August 2024

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21094428

31 August 2024

publication date

1 December 2010

1 reference

Europe PubMed Central

PubMed publication ID

7 November 2017

full work available at URL

https://api.elsevier.com/content/article/PII:S0732889310004323?httpAccept=text/xml

1 reference

10.1016/J.DIAGMICROBIO.2010.09.018

https://api.crossref.org/works/10.1016/J.DIAGMICROBIO.2010.09.018

31 August 2024

https://api.elsevier.com/content/article/PII:S0732889310004323?httpAccept=text/plain

1 reference

10.1016/J.DIAGMICROBIO.2010.09.018

https://api.crossref.org/works/10.1016/J.DIAGMICROBIO.2010.09.018

31 August 2024

Diagnostic Microbiology and Infectious Disease

1 reference

Europe PubMed Central

PubMed publication ID

7 November 2017

68

1 reference

Europe PubMed Central

PubMed publication ID

7 November 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

7 November 2017

459-467

1 reference

Europe PubMed Central

PubMed publication ID

7 November 2017

Trends in linezolid susceptibility patterns: report from the 2002-2003 worldwide Zyvox Annual Appraisal of Potency and Spectrum (ZAAPS) Program

1

1 reference

10.1016/J.DIAGMICROBIO.2010.09.018

https://api.crossref.org/works/10.1016/J.DIAGMICROBIO.2010.09.018

31 August 2024

Multicenter assessment of the linezolid spectrum and activity using the disk diffusion and Etest methods: report of the Zyvox(R) antimicrobial potency study in Latin America (LA-ZAPS).

2

1 reference

10.1016/J.DIAGMICROBIO.2010.09.018

https://api.crossref.org/works/10.1016/J.DIAGMICROBIO.2010.09.018

31 August 2024

A multicenter evaluation of linezolid antimicrobial activity in North America

3

1 reference

10.1016/J.DIAGMICROBIO.2010.09.018

https://api.crossref.org/works/10.1016/J.DIAGMICROBIO.2010.09.018

31 August 2024

Linezolid versus vancomycin for the treatment of gram-positive bacterial infections: meta-analysis of randomised controlled trials

4

1 reference

10.1016/J.DIAGMICROBIO.2010.09.018

https://api.crossref.org/works/10.1016/J.DIAGMICROBIO.2010.09.018

31 August 2024

Multicentre evaluation of the in vitro activity of linezolid in the Western Pacific

5

1 reference

10.1016/J.DIAGMICROBIO.2010.09.018

https://api.crossref.org/works/10.1016/J.DIAGMICROBIO.2010.09.018

31 August 2024

Multicentre assessment of linezolid antimicrobial activity and spectrum in Europe: report from the Zyvox antimicrobial potency study (ZAPS-Europe).

6

1 reference

10.1016/J.DIAGMICROBIO.2010.09.018

https://api.crossref.org/works/10.1016/J.DIAGMICROBIO.2010.09.018

31 August 2024

Efficacy and safety of linezolid in methicillin-resistant Staphylococcus aureus (MRSA) complicated skin and soft tissue infection (cSSTI): a meta-analysis

7

1 reference

10.1016/J.DIAGMICROBIO.2010.09.018

https://api.crossref.org/works/10.1016/J.DIAGMICROBIO.2010.09.018

31 August 2024

Penetration of linezolid into soft tissues of healthy volunteers after single and multiple doses.

11

1 reference

10.1016/J.DIAGMICROBIO.2010.09.018

https://api.crossref.org/works/10.1016/J.DIAGMICROBIO.2010.09.018

31 August 2024

Oxazolidinone antibiotics.

12

1 reference

10.1016/J.DIAGMICROBIO.2010.09.018

https://api.crossref.org/works/10.1016/J.DIAGMICROBIO.2010.09.018

31 August 2024

Microbiology of drugs for treating multiply drug-resistant Gram-positive bacteria

13

1 reference

10.1016/J.DIAGMICROBIO.2010.09.018

https://api.crossref.org/works/10.1016/J.DIAGMICROBIO.2010.09.018

31 August 2024

Safety and tolerability of linezolid

15

1 reference

10.1016/J.DIAGMICROBIO.2010.09.018

https://api.crossref.org/works/10.1016/J.DIAGMICROBIO.2010.09.018

31 August 2024

Emergence of linezolid-resistant Staphylococcus aureus during treatment of pulmonary infection in a patient with cystic fibrosis.

16

1 reference

10.1016/J.DIAGMICROBIO.2010.09.018

https://api.crossref.org/works/10.1016/J.DIAGMICROBIO.2010.09.018

31 August 2024

Nosocomial outbreak of linezolid-resistant Enterococcus faecalis infection in a tertiary care hospital

17

1 reference

10.1016/J.DIAGMICROBIO.2010.09.018

https://api.crossref.org/works/10.1016/J.DIAGMICROBIO.2010.09.018

31 August 2024

Intrapulmonary penetration of linezolid

18

1 reference

10.1016/J.DIAGMICROBIO.2010.09.018

https://api.crossref.org/works/10.1016/J.DIAGMICROBIO.2010.09.018

31 August 2024

Linezolid-resistant Staphylococcus aureus isolated from 2006 through 2008 at six hospitals in Japan

19

1 reference

10.1016/J.DIAGMICROBIO.2010.09.018

https://api.crossref.org/works/10.1016/J.DIAGMICROBIO.2010.09.018

31 August 2024

Multi-laboratory assessment of the linezolid spectrum of activity using the Kirby-Bauer disk diffusion method: Report of the Zyvox Antimicrobial Potency Study (ZAPS) in the United States

20

1 reference

10.1016/J.DIAGMICROBIO.2010.09.018

https://api.crossref.org/works/10.1016/J.DIAGMICROBIO.2010.09.018

31 August 2024

Linezolid-resistant Enterococcus faecium isolated from a patient without prior exposure to an oxazolidinone: report from the SENTRY Antimicrobial Surveillance Program

21

1 reference

10.1016/J.DIAGMICROBIO.2010.09.018

https://api.crossref.org/works/10.1016/J.DIAGMICROBIO.2010.09.018

31 August 2024

Zyvox Annual Appraisal of Potency and Spectrum Program Results for 2006: an activity and spectrum analysis of linezolid using clinical isolates from 16 countries

22

1 reference

10.1016/J.DIAGMICROBIO.2010.09.018

https://api.crossref.org/works/10.1016/J.DIAGMICROBIO.2010.09.018

31 August 2024

ZAAPS International Surveillance Program (2007) for linezolid resistance: results from 5591 Gram-positive clinical isolates in 23 countries

23

1 reference

10.1016/J.DIAGMICROBIO.2010.09.018

https://api.crossref.org/works/10.1016/J.DIAGMICROBIO.2010.09.018

31 August 2024

Zyvox Annual Appraisal of Potency and Spectrum program: linezolid surveillance program results for 2008.

24

1 reference

10.1016/J.DIAGMICROBIO.2010.09.018

https://api.crossref.org/works/10.1016/J.DIAGMICROBIO.2010.09.018

31 August 2024

Oxazolidinone susceptibility patterns in 2004: report from the Zyvox Annual Appraisal of Potency and Spectrum (ZAAPS) Program assessing isolates from 16 nations

25

1 reference

10.1016/J.DIAGMICROBIO.2010.09.018

https://api.crossref.org/works/10.1016/J.DIAGMICROBIO.2010.09.018

31 August 2024

A T2504A mutation in the 23S rRNA gene responsible for high-level resistance to linezolid of Staphylococcus epidermidis.

26

1 reference

10.1016/J.DIAGMICROBIO.2010.09.018

https://api.crossref.org/works/10.1016/J.DIAGMICROBIO.2010.09.018

31 August 2024

Dissemination of two international linezolid-resistant Staphylococcus epidermidis clones in Greek hospitals.

27

1 reference

10.1016/J.DIAGMICROBIO.2010.09.018

https://api.crossref.org/works/10.1016/J.DIAGMICROBIO.2010.09.018

31 August 2024

The Cfr rRNA methyltransferase confers resistance to Phenicols, Lincosamides, Oxazolidinones, Pleuromutilins, and Streptogramin A antibiotics

28

1 reference

10.1016/J.DIAGMICROBIO.2010.09.018

https://api.crossref.org/works/10.1016/J.DIAGMICROBIO.2010.09.018

31 August 2024

Antimicrobial resistance to linezolid

29

1 reference

10.1016/J.DIAGMICROBIO.2010.09.018

https://api.crossref.org/works/10.1016/J.DIAGMICROBIO.2010.09.018

31 August 2024

Linezolid resistance in sequential Staphylococcus aureus isolates associated with a T2500A mutation in the 23S rRNA gene and loss of a single copy of rRNA.

30

1 reference

10.1016/J.DIAGMICROBIO.2010.09.018

https://api.crossref.org/works/10.1016/J.DIAGMICROBIO.2010.09.018

31 August 2024

First report of Staphylococcal clinical isolates in Mexico with linezolid resistance caused by cfr: evidence of in vivo cfr mobilization

31

1 reference

10.1016/J.DIAGMICROBIO.2010.09.018

https://api.crossref.org/works/10.1016/J.DIAGMICROBIO.2010.09.018

31 August 2024

First report of cfr-mediated resistance to linezolid in human staphylococcal clinical isolates recovered in the United States

32

1 reference

10.1016/J.DIAGMICROBIO.2010.09.018

https://api.crossref.org/works/10.1016/J.DIAGMICROBIO.2010.09.018

31 August 2024

Linezolid: the first oxazolidinone antimicrobial

33

1 reference

10.1016/J.DIAGMICROBIO.2010.09.018

https://api.crossref.org/works/10.1016/J.DIAGMICROBIO.2010.09.018

31 August 2024

Resistance to linezolid is mediated by the cfr gene in the first report of an outbreak of linezolid-resistant Staphylococcus aureus

34

1 reference

10.1016/J.DIAGMICROBIO.2010.09.018

https://api.crossref.org/works/10.1016/J.DIAGMICROBIO.2010.09.018

31 August 2024

Linezolid resistance since 2001: SENTRY Antimicrobial Surveillance Program

35

1 reference

10.1016/J.DIAGMICROBIO.2010.09.018

https://api.crossref.org/works/10.1016/J.DIAGMICROBIO.2010.09.018

31 August 2024

Trends in linezolid susceptibility patterns in 2002: report from the worldwide Zyvox Annual Appraisal of Potency and Spectrum Program

36

1 reference

10.1016/J.DIAGMICROBIO.2010.09.018

https://api.crossref.org/works/10.1016/J.DIAGMICROBIO.2010.09.018

31 August 2024

Oxazolidinone susceptibility patterns for 2005: International Report from the Zyvox Annual Appraisal of Potency and Spectrum Study

37

1 reference

10.1016/J.DIAGMICROBIO.2010.09.018

https://api.crossref.org/works/10.1016/J.DIAGMICROBIO.2010.09.018

31 August 2024

Emergence of increasing linezolid-resistance in enterococci in a post-outbreak situation with vancomycin-resistant Enterococcus faecium

38

1 reference

10.1016/J.DIAGMICROBIO.2010.09.018

https://api.crossref.org/works/10.1016/J.DIAGMICROBIO.2010.09.018

31 August 2024

Mechanism of action of the oxazolidinone antibacterial agents

39

1 reference

10.1016/J.DIAGMICROBIO.2010.09.018

https://api.crossref.org/works/10.1016/J.DIAGMICROBIO.2010.09.018

31 August 2024

Linezolid resistance in a clinical isolate of Staphylococcus aureus

40

1 reference

10.1016/J.DIAGMICROBIO.2010.09.018

https://api.crossref.org/works/10.1016/J.DIAGMICROBIO.2010.09.018

31 August 2024

Polyphyletic emergence of linezolid-resistant staphylococci in the United States

42

1 reference

10.1016/J.DIAGMICROBIO.2010.09.018

https://api.crossref.org/works/10.1016/J.DIAGMICROBIO.2010.09.018

31 August 2024

Linezolid-resistant methicillin-resistant Staphylococcus aureus isolated after long-term, repeated use of linezolid

43

1 reference

10.1016/J.DIAGMICROBIO.2010.09.018

https://api.crossref.org/works/10.1016/J.DIAGMICROBIO.2010.09.018

31 August 2024

Identifiers

10.1016/J.DIAGMICROBIO.2010.09.018

1 reference

Europe PubMed Central

PubMed publication ID

7 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

7 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42795664&oldid=2240791861"